FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease. (2017)
Attributed to:
Alpha-1-antitrypsin (AT) deficiency and the serpinopathies: pathobiology and new therapeutic strategies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1164/rccm.201703-0449oc
PubMed Identifier: 28375647
Publication URI: http://europepmc.org/abstract/MED/28375647
Type: Journal Article/Review
Volume: 196
Parent Publication: American journal of respiratory and critical care medicine
Issue: 4
ISSN: 1073-449X